Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Roche offers lifeline: continued cancer drug access for trial patients

NCT ID NCT05862285

Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 03, 2026 · Updated 5 times

Summary

This study gives people with cancer continued access to an experimental Roche treatment they were already receiving in a previous trial. It is for patients who still need the drug and cannot get it locally. The goal is to keep providing the treatment and monitor any side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2023

Expected to finish

Mar 2033

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Eligible for continuing Roche IMP-based therapy at the time of roll-over from the parent study, as per the parent study protocol OR * Eligible for continuing the comparator agent(s) in a Genentech- or Roche-sponsored study as per the parent study protocol, with no access to commercially available comparator agent * First dose of study treatment in this extension study will be received within 7 days of the treatment interruption window allowed by the parent study * Continue to benefit from the Roche IMP-based therapy or comparator at the time of roll-over from the parent study as assessed by the investigator * Ability to comply with the extension study protocol, per Investigator's judgement Exclusion Criteria: * Meet any of the study treatment discontinuation criteria specified in the parent study at the time of enrollment in this extension study * Study treatment or comparator agent is commercially marketed in the participant's country for the participant-specific disease and is accessible to the participant * Treatment with any anti-cancer treatment (other than treatment permitted in the parent study) during the time between last treatment in the parent study and the first dose of study treatment in this extension study * Permanent discontinuation of all study treatment(s) or comparator agent(s) for any reason during the parent study or during the time between last treatment in the parent study and the first dose of study treatment in this extension study (if applicable) * Ongoing SAE(s) that has not resolved to baseline level or Grade ≤1 from the parent study or during the time between the last treatment in the parent study and the first dose of study treatment in this extension study * Concurrent participation in any therapeutic clinical trial (other than the parent study)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    55 sites in 12 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AZ Groeninge

    ACTIVE_NOT_RECRUITING

    Kortrijk, 8500, Belgium

  • Arensia Exploratory Medicine - Ukraine

    RECRUITING

    Kyiv, 02000, Ukraine

  • Asan Medical Center

    ACTIVE_NOT_RECRUITING

    Seoul, 05505, South Korea

  • Beijing Cancer Hospital

    RECRUITING

    Beijing, 100142, China

  • CHA Bundang Medical Center

    RECRUITING

    Gyeonggi-do, 13496, South Korea

  • Cancer Center of Guangzhou Medical University

    RECRUITING

    Guangzhou, 510000, China

  • Centre Francois Baclesse

    RECRUITING

    Caen, 14076, France

  • Centre Leon Berard

    RECRUITING

    Lyon, 69373, France

  • Centre Régional de Lutte Contre Le Cancer Val D'aurelle Paul Lamarque

    RECRUITING

    Montpellier, 34298, France

  • Centro Medico Culiacan SA de CV

    ACTIVE_NOT_RECRUITING

    Culiacán, Sinaloa, Mexico

  • Chang Gung Memorial Hospital - Linkou

    ACTIVE_NOT_RECRUITING

    Taoyuan, 333, Taiwan

  • Chulalongkorn Hospital

    ACTIVE_NOT_RECRUITING

    Bangkok, 10330, Thailand

  • Clinica CIMCA

    ACTIVE_NOT_RECRUITING

    San José, 10103, Costa Rica

  • Consultorio de Especialidad en Urologia Privado

    ACTIVE_NOT_RECRUITING

    Durango, 34000, Mexico

  • First Affiliated Hospital of Medical College of Xi'an Jiaotong University

    RECRUITING

    XI 'an City, Shaanxi Province, Shaanxi, 710061, China

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Shanghai, 200120, China

  • GHdC Site Les Viviers

    COMPLETED

    Charleroi, 6060, Belgium

  • General Hospital "G.Papanikolaou"

    RECRUITING

    Asvestochóri, 570 10, Greece

  • Gustave Roussy

    RECRUITING

    Villejuif, 94800, France

  • Harbin Medical University Cancer Hospital

    RECRUITING

    Harbin, 150081, China

  • Henan Cancer Hospital

    RECRUITING

    Zhengzhou, 450008, China

  • Hopital Tenon

    RECRUITING

    Paris, 75970, France

  • Hopital de la Timone

    RECRUITING

    Marseille, 13005, France

  • ICIMED Instituto de Investigación en Ciencias Médicas

    ACTIVE_NOT_RECRUITING

    San José, 10108, Costa Rica

  • ICO - Site René Gauducheau

    RECRUITING

    Saint-Herblain, 44805, France

  • Institut Bergonie

    RECRUITING

    Bordeaux, 33076, France

  • Institut Claudius Regaud

    RECRUITING

    Toulouse, 31059, France

  • Institut Curie

    RECRUITING

    Paris, 75005, France

  • Institut de Cancérologie de Bourgogne

    RECRUITING

    Dijon, 21000, France

  • Institut de cancerologie du Gard

    COMPLETED

    Nîmes, 30029, France

  • Jiangsu Province Hospital of Chinese Medicine

    RECRUITING

    Nanjing, 210029, China

  • Kanagawa Cancer Center

    COMPLETED

    Kanagawa, 241-8515, Japan

  • Kyushu University Hospital

    RECRUITING

    Fukuoka, 812-8582, Japan

  • Leicester Royal Infirmary

    RECRUITING

    Leicester, LE1 5WW, United Kingdom

  • Maharaj Nakorn Chiangmai Hospital

    ACTIVE_NOT_RECRUITING

    Chiang Mai, 50200, Thailand

  • Medical Care & Research

    COMPLETED

    Mérida, Yucatán, 97070, Mexico

  • Meizhou People's Hospital

    RECRUITING

    Meizhou, 514031, China

  • Metropolitan General Hospital

    RECRUITING

    Cholargós, 155 62, Greece

  • Moscow City Oncology Hospital #62

    RECRUITING

    Moscovskaya Oblast, Moscow Oblast, 143423, Russia

  • NHO Kinki-Chuo Chest Medical Center

    RECRUITING

    Sakaishi, 591-8555, Japan

  • Nanfang Hospital, Southern Medical University

    RECRUITING

    Guangzhou, 510515, China

  • Narodowy Instytut Onkologii im. M.Sklodowskiej-Curie

    RECRUITING

    Warsaw, 02-781, Poland

  • National Cancer Center

    RECRUITING

    Goyang-si, 10408, South Korea

  • National Cancer Center Hospital East

    RECRUITING

    Chiba, 277-8577, Japan

  • National Cancer Center Hospital East

    RECRUITING

    Kashiwa-shi, 277-8577, Japan

  • National Cheng Kung University Hospital

    RECRUITING

    Tainan, 70457, Taiwan

  • National Taiwan University Hospital

    RECRUITING

    Taipei, 110, Taiwan

  • P.A. Herzen Oncological Inst.

    RECRUITING

    Moscow, Moscow Oblast, 125248, Russia

  • Princess Margaret Cancer Center

    RECRUITING

    Toronto, Ontario, M5G 1Z5, Canada

  • Royal Marsden Hospital - Surrey

    COMPLETED

    Surrey, SM2 5PT, United Kingdom

  • Russian Scientific Center of Roentgenoradiology

    ACTIVE_NOT_RECRUITING

    Moscow, Moscow Oblast, 117997, Russia

  • Saitama Cancer Center

    RECRUITING

    Saitama, 362-0806, Japan

  • Samsung Medical Center

    RECRUITING

    Seoul, 06351, South Korea

  • Seoul National University Bundang Hospital

    COMPLETED

    Seongnam-si, 463-707, South Korea

  • Shanghai Geriatric Medical Center

    RECRUITING

    Shanghai, 201104, China

  • Sir Run Run Shaw Hospital Zhejiang University

    RECRUITING

    Hangzhou, 310016, China

  • Siriraj Hospital

    RECRUITING

    Bangkok, 10700, Thailand

  • Szpital Wojewódzki im. Miko?aja Kopernika

    RECRUITING

    Koszalin, 75-581, Poland

  • Taichung Veterans General Hospital

    RECRUITING

    Taichung, 407, Taiwan

  • The 1st Affiliated Hospital of Nanchang Unversity

    RECRUITING

    Nanchang, 330052, China

  • The First Affiliated Hospital of Xiamen University

    RECRUITING

    Xiamen, 361003, China

  • The First Affiliated Hospital of Xinxiang Medical University

    RECRUITING

    Xinxiang, China

  • The Second Affiliated Hospital of Anhui Medical University

    RECRUITING

    Hefei, 230601, China

  • Tianjin Cancer Hospital

    RECRUITING

    Tianjin, 300060, China

  • Toranomon Branch Hospital

    RECRUITING

    Kanagawa, 213-8587, Japan

  • UZ Leuven Gasthuisberg

    COMPLETED

    Leuven, 3000, Belgium

  • Uniwersyteckie Centrum Kliniczne

    RECRUITING

    Gda?sk, 80-214, Poland

  • West China Hospital of Sichuan University

    RECRUITING

    Chengdu, 610041, China

  • Xiehe Hospital, Tongji Medical College Huazhong University of Science & Technology

    RECRUITING

    Wuhan, Hubei, 430048, China

  • Yokohama City University Medical Center

    ACTIVE_NOT_RECRUITING

    Kanagawa, 232-0024, Japan

  • Zhejiang Cancer Hospital

    RECRUITING

    Hangzhou, 310022, China

  • the First Hospital of Jilin University

    RECRUITING

    Changchun, 130021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.